These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1601361)

  • 21. [The blood serum lipid spectrum in diabetes mellitus].
    Ibragimov TK
    Probl Endokrinol (Mosk); 1990; 36(5):33-4. PubMed ID: 2080139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The metabolic consequences of long-term human obesity.
    Felber JP; Golay A; Jéquier E; Curchod B; Temler E; DeFronzo RA; Ferrannini E
    Int J Obes; 1988; 12(5):377-89. PubMed ID: 3069764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diabetes mellitus and lipoproteins].
    Somogyi A
    Orv Hetil; 1993 Oct; 134(43):2371-7. PubMed ID: 8233456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postprandial lipaemia in patients with impaired fasting glucose, impaired glucose tolerance and diabetes mellitus.
    Madhu SV; Kant S; Srivastava S; Kant R; Sharma SB; Bhadoria DP
    Diabetes Res Clin Pract; 2008 Jun; 80(3):380-5. PubMed ID: 18321605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fenofibrate 250 SR Pharmavit in patients with mixed hyperlipoproteinemia. Results of a study of 189 patients from 13 centers in the Czech Republic].
    Ceska R; Stulc T
    Cas Lek Cesk; 2000 Jun; 139(12):369-73. PubMed ID: 10953407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma-insulin response to glucose and circulating serum lipid levels in first-degree relatives of diabetic patients.
    Jakobson T
    Ann Clin Res; 1972 Apr; 4(2):70-7. PubMed ID: 5028067
    [No Abstract]   [Full Text] [Related]  

  • 29. [Metabolic disorders in hyperuricemia].
    Turpin G
    Rev Prat; 1983 Oct; 33(43):2271-80. PubMed ID: 6635505
    [No Abstract]   [Full Text] [Related]  

  • 30. Subcutaneous microdialysis before and after an oral glucose tolerance test: a method to determine insulin resistance in the subcutaneous adipose tissue in diabetes mellitus.
    Rajamand N; Ungerstedt U; Brismar K
    Diabetes Obes Metab; 2005 Sep; 7(5):525-35. PubMed ID: 16050945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rhodiola crenulata root ameliorates derangements of glucose and lipid metabolism in a rat model of the metabolic syndrome and type 2 diabetes.
    Wang J; Rong X; Li W; Yang Y; Yamahara J; Li Y
    J Ethnopharmacol; 2012 Aug; 142(3):782-8. PubMed ID: 22683493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Carbohydrate and lipid metabolism disorders in obese children and adolescents].
    Iwanicka Z; Głab E; Barg E
    Med Wieku Rozwoj; 2004; 8(3 Pt 2):815-24. PubMed ID: 15858253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The metabolic syndrome and hyper-Lp(a)-lipoproteinemia in peripheral obliterative atherosclerosis: 2 case reports].
    Tesić D; Derić M; Ivković-Lazar T; Pantelinac P; Lepsanović L
    Med Pregl; 1996; 49(7-8):313-7. PubMed ID: 8926951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fasting blood glucose and insulin sensitivity are unaffected by HAART duration in Cameroonians receiving first-line antiretroviral treatment.
    Ekali LG; Johnstone LK; Echouffo-Tcheugui JB; Kouanfack C; Dehayem MY; Fezeu L; Nouthe B; Hayes L; Unwin NC; Sobngwi E
    Diabetes Metab; 2013 Feb; 39(1):71-7. PubMed ID: 23153435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination lipid therapy in type 2 diabetes mellitus.
    Vergès B
    Expert Opin Pharmacother; 2011 Jun; 12(9):1393-403. PubMed ID: 21323502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Total and lipid-bound sialic acids in the blood in primary and secondary hyperlipoproteinemias].
    Tvorogova MG; Rozhkova TA; Lupanov VP; Liakishev AA; Titov VN
    Ter Arkh; 1997; 69(1):23-5. PubMed ID: 9163043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS; Kashyap ML
    Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Blood uric acid levels and overweight: correlations in clinical cases of diabetic patients].
    Sinagra D; Cangemi C; Lombardo G; Randazzo C
    Medicina (Firenze); 1988; 8(1):77-8. PubMed ID: 3226252
    [No Abstract]   [Full Text] [Related]  

  • 39. Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus.
    Ringel J; Engeli S; Distler A; Sharma AM
    Biochem Biophys Res Commun; 1999 Jan; 254(2):450-3. PubMed ID: 9918859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hypertension and multimetabolic syndrome].
    Suba I; Halmos T; Kautzky L; Jakab A
    Orv Hetil; 1993 Feb; 134(8):395-9. PubMed ID: 8441528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.